Big Drug Company CEOs to Testify at Senate Health Committee on Insulin Prices
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.
Stay updated with breaking news from David Joyner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.
Plus: Taconic Partners' Upper East Side lab totaling $350M to open in 2025 Mount Sinai gets $60M to build Tisch Cancer Hospital Community Healthcare Network secures 35-year lease for Bronx FQHC
The top toy company Mattel shocked fans with an extreme makeover for the popular children's dinosaur Barney. The internet reacted negatively to the rebranding and called it a "nightmare."